{"id":15859,"date":"2021-12-14T20:53:40","date_gmt":"2021-12-14T19:53:40","guid":{"rendered":"https:\/\/convergences.online\/hemato\/?p=15859"},"modified":"2021-12-14T20:53:40","modified_gmt":"2021-12-14T19:53:40","slug":"deploiement-du-projet-lysoneo-une-etude-pilote-pour-depister-les-maladies-lysosomales-a-la-naissance","status":"publish","type":"post","link":"https:\/\/www.hematostat.net\/en\/deploiement-du-projet-lysoneo-une-etude-pilote-pour-depister-les-maladies-lysosomales-a-la-naissance\/","title":{"rendered":"D\u00e9ploiement du projet LysoNeo, une \u00e9tude pilote pour d\u00e9pister les maladies lysosomales \u00e0 la naissance."},"content":{"rendered":"<p>D\u00e9pister certaines maladies lysosomales graves \u00e0 la naissance est-il opportun et r\u00e9alisable ? Pour le savoir, l&#8217;h\u00f4pital Charles Nicolle du CHU de Rouen a d\u00e9but\u00e9 d\u00e9but mars 2021 la collecte d\u2019\u00e9chantillons sanguins de tous les nouveau-n\u00e9s normands dans le cadre du projet LysoNeo. Ce projet concernera au total 100 000 b\u00e9b\u00e9s et durera 3 ans. Cette \u00e9tude pilote vise \u00e0 \u00e9valuer la faisabilit\u00e9 pratique et op\u00e9rationnelle d\u2019\u00e9tendre le d\u00e9pistage n\u00e9onatal national aux maladies lysosomales, sous-groupe de maladies g\u00e9n\u00e9tiques rares, \u00e0 partir d\u2019une goutte de sang d\u00e9pos\u00e9e sur un papier buvard. Une premi\u00e8re en France dans le domaine de la p\u00e9rinatalit\u00e9, pr\u00e9sent\u00e9e le 14 d\u00e9cembre au CHU de Rouen.<\/p>","protected":false},"excerpt":{"rendered":"<p>D\u00e9pister certaines maladies lysosomales graves \u00e0 la naissance est-il opportun et r\u00e9alisable ? Pour le savoir, l&#8217;h\u00f4pital Charles Nicolle du CHU de Rouen a d\u00e9but\u00e9 d\u00e9but mars 2021 la collecte [&hellip;]<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"categories":[21],"tags":[],"ppma_author":[442],"class_list":["post-15859","post","type-post","status-publish","format-standard","hentry","category-communique-de-presse","author-marion"],"aioseo_notices":[],"authors":[{"term_id":442,"user_id":2,"is_guest":0,"slug":"marion","display_name":"HematoStat.net (M)","avatar_url":{"url":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png","url2x":"https:\/\/www.hematostat.net\/wp-content\/uploads\/2024\/01\/favicon-hematoStat.png"},"first_name":"HematoStat.net (M)","last_name":"","user_url":"","description":""}],"_links":{"self":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15859","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/comments?post=15859"}],"version-history":[{"count":0,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/posts\/15859\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/media?parent=15859"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/categories?post=15859"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/tags?post=15859"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.hematostat.net\/en\/wp-json\/wp\/v2\/ppma_author?post=15859"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}